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ORIGINAL ARTICLERate of the incidence of hospital-acquired infections in Iran based on the
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University of Medical Sciences and 4) Prevention of Cardiovascular Disease Research Centre, Department of Epidemiology, School of Public Health and Safety,
Shahid Beheshti University of Medical Sciences, Tehran, IranAbstractHospital-acquired infections (HAIs) lead to increased length of hospital stay, inappropriate use of broad-spectrum antibiotics and multiple
antibiotic resistance. This study aimed to investigate the rate of HAIs in Iran. In this multi-centre study, the rate of HAIs was calculated
based on the data collected through Iranian nosocomial infections surveillance for patients with HAIs, as well as through hospital
statistics and information systems on hospital-related variables. Data were analysed using STATA software; in addition, ArcGIS was used
for plotting the geographical distribution of HAIs by different provinces. The mean age of the 107 669 patients affected by HAIs was
52 ± 26.71 years. Just over half (51.55%) of the patients were male. The overall rate of HAIs was 26.57 per 1000 patients and 7.41 per
1000 patient-days. The most common HAIs were urinary tract infections (26.83%; 1.99 per 1000 patient-days), ventilator-associated
events (20.28%; 1.5 per 1000 patient-days), surgical-site infections (19.73%; 1.45 per 1000 patient-days) and bloodstream infections
(13.51%; 1 per 1000 patient-days), respectively. The highest rate of HAIs was observed in intensive care units. Device, catheter and
ventilator-associated infections accounted for 38.72%, 18.79% and 16% of all HAIs, respectively. Based on the results, HAIs are common
in intensive care units, and urinary tract infections and device-related infections are more prevalent in Iran. To reduce HAIs it is
recommended to implement appropriate policies and interventions, train staff about the use of devices, and prepare and update
protocols and guidelines for improving the quality of care.
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E-mail: saeedh_1999@yahoo.comIntroductionHospital-acquired infections (HAIs) are one of the causes of
adverse events, mortality and reduced quality of life in hospi-
talized individuals, especially in developing countries; they lead
to increased hospital length of stay (LOS), increased medicalThis is an open access artiand health-care system costs, inappropriate use of broad-
spectrum antibiotics and multiple antibiotic resistance [1].
By definition, HAIs refers to infections that are not present
at admission and occur within 48–72 hours after admission or
up to 6 weeks after discharge, not during the incubation period
[2]. In addition, infections acquired by staff in a hospital setting
or infections of neonates occurring in the birth canal are also
considered as HAIs [3].
Hospital-acquired infections are estimated to account for a
financial loss of $4.5 billion and amortality rate of 88 000 annually,
whereas the total costs spent on controlling HAIs is much lower
than the cost of their treatment [4]. The most important types of
HAIs are catheter-associated urinary tract infections (CAUTI),
ventilator-associated events/respiratory infections/pneumoniaNew Microbe and New Infect 2020; 38: 100768
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bloodstream infections/septicaemia (CLABSI). Device-related
infections including VAP, CAUTI and CLABSI account for
25.6% and SSIs accounts for 21.8% of HAIs. These two groups of
infections together account for 47.4% of all HAIs [5].
The high prevalence of infections caused by urinary catheters
leads to a cumulative increase in the burden as well as com-
plications of and deaths from UTIs [3]. VAP is an iatrogenic
infection with a mortality rate of approximately 10% [6,7],
which is estimated to affect more than 250 000 Americans
annually [8]. SSI is associated with an increase of 60% in the risk
of intensive care unit (ICU) admission, 6.5 days of increase in
LOS, $300 of increase in hospital costs, and a five-fold increase
in readmission [5]. In addition, statistical data have shown that
the rate of bloodstream infection (BSI) in hospitalized patients is
about 1% and the rate of mortality is about 25%–30%,
increasing by 50% with increasing severity of sepsis [9].
A meta-analysis study of the burden of HAIs in Southeast
Asia in 2015 showed that the pooled prevalence of overall HAIs
was 9%. Also, the pooled incidences of VAP, CLABSI and
CAUTI were 14.7 per 1000 ventilator-days, and 4.7 and 8.9 per
1000 catheter-days, respectively. The attributed mortality of
infected patients varied from 7% to 46% [10]. In the Zhang et al.
survey of 5 868 147 patients in 189 hospitals in Guangdong
province, China, 1.24% had one or more HAIs [11]. The
prevalences of device-associated infections, including VAP,
CAUTI and CLABSI were 7.92 per 1000 ventilator-days, and
2.06 and 0.63 per 1000 catheter-days, respectively [11].
In Iran, statistical data have shown that the prevalence of
HAIs is 1.3%–10% [12–14]. Various factors such as surgery,
immune system disorders, use of immunosuppressant drugs,
chronic diseases such as diabetes, cirrhosis, renal failure, can-
cers, use of broad-spectrum antibiotics, as well as some ther-
apeutic interventions such as intubation, venepuncture and
endoscopy have an important role in increasing the prevalence
of HAIs [15]. Based on the national point prevalence survey
developed by the European Centre for Disease Prevention and
Control, variables associated with HAIs included age and male
sex, surgery during current hospitalization, and presence of
central venous or urinary catheters [16].
Prevention of HAIs is essential and within the focus of the
health-care system. Many factors contribute to the spread of
these infections and HAI control is now a global priority.
Because accurate measurements are needed to improve any
situation, infection control measures must first include the
precise determination of hospital-level infections using reliable
data. Studies have shown that feedbacks on health-care out-
comes for different types of infections in hospitals can reduce© 2020 The Author(s). Published by Elsevier Ltd, NMNI, 38, 100768
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licethe incidence of infection [17,18]. This study aimed to investi-
gate the rate of HAIs in Iran in 2017.MethodsData sources
Iranian nosocomial infections surveillance (INIS). Using the stan-
dard definitions defined by the national hospital-acquired in-
fections surveillance system (INIS) as a method for diagnosing
HAIs, the national infectious control committee registers the
four main groups of infection including the following: CAUTI,
VAP, SSI and CLABSI. The data are collected with the aim of
reducing mortality, morbidity and complications of HAIs,
reducing hospital costs through decreasing the average length of
hospitalization and therapeutic interventions, maintaining and
promoting health, and increasing patient satisfaction.
Iranian nosocomial infection surveillancewas developed in2010
and now collects data from about 787 hospitals and records
different types of information including age, gender, number of
hospitalizations, number of deaths, number of surgeries, date of
infection, province, university, affiliated organization, devices used
(urinary, artery, umbilical, peripheral, and permanent and tem-
porary central venous catheter) and outcome of infection.
Hospital statistics and information system (AVAB). The hospital
statistics and information system is a web-based system for
monitoring and evaluation of different hospitals. Its objective is to
facilitate the process of policy-making and planning in the field of
health and to meet equitable allocation of resources. The system
records hospital characteristics including province, university,
affiliated organization, accreditation degree, activity status, type
of specialty, ward type and performance indicators including the
average LOS and bed occupancy in 972 hospitals in Iran.
In this multi-centre study, INIS was used to collect data on
patients with HAIs (107 669 patients with HAIs in 2017) and
AVAB was used to collect data on hospital-related variables and
their linkage to calculate the rate of HAIs (i.e. data on 744
hospitals).
Statistical analysis
Mean (standard deviation) was used to describe quantitative
variables and frequency (percentage) was used to assess quali-
tative variables. Infections occurring within less than 48 hours
of hospitalization were excluded from the calculation of length
of hospitalization until infection and the total length of hospi-
talization. Data were analysed using STATA software (version 12)
(StataCorp, College Station, TX, USA).nses/by-nc-nd/4.0/).
TABLE 1. Distribution of hospitalization-infection length and
length of hospitalization by gender among hospital-acquired
infection patients in Iran 2017
Gender
Hospitalization until infection
length Length of hospitalization
n Mean ± SD
Median
(Q1–Q3) n Mean ± SD
Median
(Q1–Q3)
Male 55 149 16.06 ± 32.69 7 (2–18) 48 370 31.5 ± 46.41 20 (9–38)
Female 52 113 14.22 ± 32.08 6 (2–15) 46 038 26.83 ± 43.58 15 (7–32)
Missing 137 9.31 ± 12.12 4 (2–13) 96 28 ± 22.94 23
(13–36.5)
Total 107 669 15.16 ± 32.39 7 (2–17) 94 408 29.22 ± 45.1 17 (8–35)
NMNI Izadi et al. Hospital-acquired infections rate in Iran 3For each variable, the rate per patient was calculated by
dividing total number of patients with HAIs by total number of
hospitalizations multiplied by 1000.
The rate per patient-day for each variable was calculated by
dividing total number of patients with HAIs by the total average
patient-days multiplied by 1000. In addition, the average patient-
days was calculated by the number of hospitalizations (based on
the data collected from INIS) multiplied by the average LOS
(based on the data collected from AVAB).
For each infection type, the rate per device-day was calcu-
lated by dividing total number of HAIs by total device-days
multiplied by 1000. For SSIs, total number of SSIs was divided
by total number of surgeries in each hospital. In addition,
device-associated infections rate was calculated by dividing total
number of HAIs related to ventilator and catheters by total
device-days multiplied by 1000.ResultsThe mean age of 107 669 patients with HAIs was 52 ± 26.71
years (51.93 ± 27.23 years in men and 52.09 ± 26.12 years in
women). Just over half (51.47%; 55 419) of patients were male
(sex ratio: 1.06 male/female).
The mean length of hospitalization was 29.22 ± 45.1 days
(31.5 ± 46.42.23 days in men and 26.83 ± 43.58 days in women)
(Table 1).
Based on data collected from 744 hospitals, the overall rate
of HAIs was 26.57 per 1000 patients and 7.41 per 1000 patient-
days (2.65% of the patients had HAIs). The rate of HAIs per
1000 patient-days was 7.01 in government hospitals and 8.24 in
profit hospitals (Table 2).
The highest rate of HAIs per 1000 patients and per 1000
patient-days by ward type was observed in general ICU,
transplant, internal ICU and surgical ICU (Fig. 1). The most
common HAIs in patients were UTI (26.83%; 7.13 per 1000
patients and 1.99 per 1000 patient-days), VAP (20.28%; 5.39 per
1000 patients and 1.5 per 1000 patient-days), SSI (19.73%; 5.24
per 1000 patients and 1.45 per 1000 patient-days) and BSI
(13.51%; 3.59 per 1000 patients and 1 per 1000 patient-days)
(Fig. 2).
Concerning device-days, the rate of VAP, pneumonia and
lower respiratory tract infections was 97.48 per 1000 device-
days and the rate of SSI was 25.37 per 1000 surgeries
(Table 3). Device, catheter and ventilator-associated infections
accounted for 38.72%, 18.79% and 16% of HAIs, respectively.
The most common catheter-associated infection was urinary
tract infection (17.25 per 1000 device-days) (Table 4).This is an open access articDiscussionHospital-acquired infections are a major problem for patient
safety and can increase financial and non-financial burdens
imposed on the health-care system [19,20]. In the present
study, the overall rate of HAIs was 26.57 per 1000 patients
(2.62%) and 7.41 per 1000 patient-days, which is lower than the
rates observed in other low- and middle-income countries
[21,22]. In addition, the most common HAIs were UTI
(26.83%), VAP (20.28%), SSI (19.73%) and BSI (13.51%).
In Labi et al.’s study, the overall prevalence of HAIs in Ghana
was 8.2%. The most common HAIs were SSIs (32.6%), BSIs
(19.5%), UTIs (18.5%) and VAP (16.3%) [20]. In China, the
prevalence of HAIs among 53 939 patients was 3.7%. In addi-
tion, the most prevalent HAIs were lower respiratory tract
infections (47.2%), UTI (12.3%), upper respiratory tract in-
fections (11%) and SSI (6.2%) [23]. Rafter et al. reported that
the prevalence of HAIs’ adverse events in Ireland was 4.4% with
an incidence of 38 per 1000 admissions [19]. Moreover, Bianco
et al. detected 147 HAIs in 1283 patients, with an incidence rate
of 17.4 per 1000 patient-days [24], which is higher than the rate
observed in our study.
In a meta-analysis of studies in Iran in 2018, the highest prev-
alence of HAIs was related to BSIs (9%), pneumonia (7.1%), SSIs
(4.4%) and UTIs (3.1%), respectively [25]. The findings of our
study about the most common HAIs are consistent with the
results of Eshrati et al.’s 2018 study conducted on 7 018 393 cases
of hospitalizations, and Zahraei et al.’s study in 2012 conducted
on 1 879 356 patients admitted to hospitals in Iran; these two
studies reported UTIs and VAP as the most prevalent types of
infection, respectively [26,27]. The incidence rate of HAIs was
11.81 per 1000 hospitalizations in 491 hospitals in Iran [26].
Hospital-acquired infections were more prevalent in ICU
wards. Similar findings have been reported in other studies
[28,29]. In this study, device-, catheter- and ventilator-© 2020 The Author(s). Published by Elsevier Ltd, NMNI, 38, 100768
le under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
TABLE 2. Hospital-acquired infections count and rate by affiliation in Iran-2017
Variables n % No. of hospitalizations Rate per 1000 patients Average patient-days Rate per 1000 patient-days
Government 79 266 82.17 2 909 132 27.25 11 263 504.8 7.01
Semi-government 4181 4.33 160 777 26 455 574.1 9.18
Profit 8522 8.83 366 486 23.25 1 034 378 8.24
Non-profit/other 2353 2.44 119 826 19.64 260 015.4 9.05
Not clear 2149 2.23 74 308 28.92 — —
Total 96 471 100 3 630 529 26.57 13 013 472.7 7.41
FIG. 1. Hospital-acquired infection
rates per 1000 patients and per 1000
patient-days by ward type in Iran
2017.
FIG. 2. Hospital-acquired infection rates per 1000 patients and per 1000 patient-days by infection type in Iran 2017.
4 New Microbes and New Infections, Volume 38 Number C, November 2020 NMNI
© 2020 The Author(s). Published by Elsevier Ltd, NMNI, 38, 100768
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
TABLE 3. Hospital-acquired infections count and rate (based
on device-days) by infection type in Iran 2017






events and lower respiratory tract infection
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Blood stream infection 13 038 346 3b 37.65
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Surgical-site infection 19 031 750 029d 25.37e
aVentilator-days;









Rate per 1000 device-
days
Urinary catheter 13 262 768 843 17.25
Arterial catheters 125 38 542 3.24
Umbilical catheters 92 5878 15.65
Peripheral venous catheter 1471 2 300 782 0.64
Permanent central venous
catheter
522 57 663 9.05
Temporary central venous
catheter
2660 288 670 9.21
Ventilator 15 445 292 433 52.82
Others 3773 — —
Catheter-Total 18 132 3 752 811 4.83
Device-Total 37 350 3 460 378 1.79
NMNI Izadi et al. Hospital-acquired infections rate in Iran 5associated infections accounted for 38.72%, 18.79% and 16% of
HAIs, respectively, though other studies have reported lower
rates. Device-associated infections accounted for only 7.1% and
7.9% of all HAIs in the studies by Labi et al. and Chen et al.,
respectively [20,23]. In addition, concerning device-days (cath-
eter-days and ventilator-days), the rate of HAIs observed in our
study is much higher than those reported in other studies
[30,31], this could be because other studies have been con-
ducted in only one ward of a hospital.
Our study had some limitations. First, it was based on 1-year
calculations of rates and geographical distribution; we did not ac-
cess information about HAIs over different years. Calculation of
incidence rate over several years could show a trend of changes in
HAI rates in Iran. Second, the data were not collected from all
hospitals in Iran. However, this study was conducted using regis-
tered data with a coverage of about 76.5% that was randomly
collected from all provinces, so it can be claimed that the results
are reliable. In addition, this study was the largest of its type; it was
the first comprehensive study that was conducted using data
registered by INIS and AVAB. It used data that assessed the rate of
HAIs using both patient-days and device-days in Iran, which might
be more accurate and can be a better indicator to follow HAIs.This is an open access articConclusionBased on the results of our study, HAIs are common in ICU
wards, and UTIs and device-related infections are more prev-
alent in Iran. These infections lead to prolonged hospital LOS
and increased costs for patients and the health-care system. To
reduce HAIs it is recommended to implement appropriate
policies and interventions, train staff about the use of devices
(catheters and ventilators), and prepare and update protocols
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